IXJ Among Health Care ETFs
End-of-day Nov 18, 2026 · 39 Health care ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.8% | −3.6% | +1.5% | +4.8% | +14.7% | +17.7% | +42.9% | +35.7% | +171.5% | +456.3% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$116 of every $1,000 in IXJ is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 11.60% | $1,159.89 | 381K | $539.5M |
| 2 | JNJJohnson & Johnson | Healthcare | 6.88% | $687.76 | 1.1M | $319.9M |
| 3 | ABBVAbbvie | Healthcare | 5.30% | $529.86 | 842K | $246.5M |
| 4 | MRKMerck | Healthcare | 3.98% | $397.71 | 1.3M | $185.0M |
| 5 | UNHUnitedhealth Group | Healthcare | 3.94% | $393.86 | 470K | $183.2M |
| 6 | ROP.SWRoche PS PAR AG | Healthcare | 3.83% | $382.98 | 368K | $178.1M |
| 7 | NOVN.SWNovartis AG | Healthcare | 3.28% | $327.56 | 959K | $152.4M |
| 8 | AZN.LAstrazeneca | Healthcare | 3.18% | $318.34 | 812K | $148.1M |
| 9 | TMOThermo Fisher Scientific | Healthcare | 2.86% | $285.96 | 194K | $133.0M |
| 10 | AMGNAmgen | Healthcare | 2.79% | $278.77 | 283K | $129.7M |
| 11 | GILDGilead Sciences | Healthcare | 2.38% | $237.80 | 650K | $110.6M |
| 12 | ABTAbbott Laboratories | Healthcare | 2.04% | $204.02 | 906K | $94.9M |
| 13 | PFEPfizer | Healthcare | 1.83% | $182.72 | 3.0M | $85.0M |
| 14 | ISRGIntuitive Surgical | Healthcare | 1.71% | $171.36 | 185K | $79.7M |
| 15 | DHRDanaher | Healthcare | 1.59% | $159.05 | 328K | $74.0M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly | 11.60% |
| 2 | JNJ | Johnson & Johnson | 6.88% |
| 3 | ABBV | Abbvie | 5.30% |
| 4 | MRK | Merck & | 3.98% |
| 5 | UNH | Unitedhealth Group | 3.94% |
| 6 | ROP.SW | Roche PS PAR AG | 3.83% |
| 7 | NOVN.SW | Novartis AG | 3.28% |
| 8 | AZN.L | Astrazeneca | 3.18% |
| 9 | TMO | Thermo Fisher Scientific | 2.86% |
| 10 | AMGN | Amgen | 2.79% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 15, 2026 | Jun 18, 2026 | $0.85 |
| Dec 16, 2025 | Dec 19, 2025 | $0.60 |
| Jun 16, 2025 | Jun 20, 2025 | $0.76 |
| Dec 17, 2024 | Dec 20, 2024 | $0.62 |
| Jun 11, 2024 | Jun 17, 2024 | $0.67 |
| Dec 20, 2023 | Dec 27, 2023 | $0.56 |
| Jun 7, 2023 | Jun 13, 2023 | $0.64 |
| Dec 13, 2022 | Dec 19, 2022 | $0.44 |
| Jun 9, 2022 | Jun 15, 2022 | $0.55 |
| Dec 13, 2021 | Dec 17, 2021 | $0.48 |
| Jun 10, 2021 | Jun 16, 2021 | $0.53 |
| Dec 14, 2020 | Dec 18, 2020 | $0.44 |